AbbVie
ABBV
#25
Rank
ยฃ386.01 B
Marketcap
ยฃ218.38
Share price
0.64%
Change (1 day)
31.33%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of June 2026 : -ยฃ4.39 Billion

According to AbbVie's latest financial reports the company has -ยฃ4.39 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$ยฃ8.16 B-42.89%
2022-12-31$ยฃ14.28 B24.95%
2021-12-31$ยฃ11.43 B19.01%
2020-12-31$ยฃ9.60 B-254.18%
2019-12-31$-ยฃ6.24 Billion-6.34%
2018-12-31$-ยฃ6.66 Billion-276.43%
2017-12-31$ยฃ3.77 B0.38%
2016-12-31$ยฃ3.75 B41.14%
2015-12-31$ยฃ2.66 B137.92%
2014-12-31$ยฃ1.11 B-58.91%
2013-12-31$ยฃ2.72 B30.88%
2012-12-31$ยฃ2.08 B-72.9%
2011-12-31$ยฃ7.67 B-24.53%
2010-12-31$ยฃ10.17 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
ยฃ63.68 B-1,551.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ29.99 B-783.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ8.70 B-298.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ14.04 B-420.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ8.74 B-299.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ17.43 B-497.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ37.52 B-955.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ18.14 B-513.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
ยฃ2.75 B-162.73%๐Ÿ‡บ๐Ÿ‡ธ USA